Stockreport

Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF – IPI-549 with AB928 and AB122 in Triple Negative Breast Cancer and Ovarian Cancer – – IPI-549 with AB928 and Chemotherapy in Triple Negative Bre [Read more]